Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,272 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | completed | Phase 2 | 124 | Bristol-Myers SquibbINDUSTRY | 20 | Aug 10, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00417911 | Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients | completed | Phase 3 | 400 | Nordic Myeloma Study GroupOTHER | 5 | Jun 22, 2010 | clinicaltrials |
| NCT00508209 | Bortezomib and High-dose Melphalan at Myeloma Relapse | unknown | Phase 2 | 50 | Nordic Myeloma Study GroupOTHER | 3 | Jun 22, 2010 | clinicaltrials |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 1,302 | Eli Lilly and CompanyINDUSTRY | 17 | Apr 12, 2010 | clinicaltrials |
| NCT00533364 | Effect of SBG in Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Biotec Pharmacon ASAINDUSTRY | 1 | Feb 18, 2010 | clinicaltrials |
| NCT00672282 | Casodex vs Placebo in Non-Metastatic Early Prostate Cancer(SPCG6) | completed | Phase 3 | 1,218 | AstraZenecaINDUSTRY | 4 | May 27, 2009 | clinicaltrials |
| NCT00275210 | MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer | completed | Phase 3 | 2,246 | SanofiINDUSTRY | 19 | Apr 20, 2009 | clinicaltrials |
| NCT00533728 | Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma | completed | Phase 1 | 12 | Biotec Pharmacon ASAINDUSTRY | 1 | Mar 4, 2009 | clinicaltrials |
| NCT00005052 | Vaccine Therapy in Treating Patients With Primary Stage II Melanoma | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 9, 2009 | clinicaltrials |
| NCT00546039 | Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer | unknown | Phase 2 | 47 | University Hospital, AkerOTHER | 1 | Sep 30, 2008 | clinicaltrials |
| NCT00455416 | Dietary Intervention in Follicular Lymphoma(KLYMF) | unknown | Phase 2 | 45 | Oslo University HospitalOTHER | 1 | May 21, 2008 | clinicaltrials |
| NCT00201435 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | completed | Phase 2 / Phase 3 | 224 | Norwegian Breast Cancer GroupOTHER | 1 | May 20, 2008 | clinicaltrials |
| NCT00358566 | GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer | terminated | Phase 3 | 360 | Pharmexa A/SINDUSTRY | 12 | May 19, 2008 | clinicaltrials |
| NCT00398970 | Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer. | completed | N/A | 240 | Haukeland University HospitalOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00319618 | Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 1 | Dec 18, 2007 | clinicaltrials |
| NCT00232726 | Clinical Study of Previously Untreated Patients With Malignant Melanoma | completed | Phase 2 | 42 | Clavis PharmaINDUSTRY | 3 | Jul 10, 2007 | clinicaltrials |
| NCT00376883 | Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month | completed | Phase 3 | 500 | Nordic Myeloma Study GroupOTHER | 3 | Jan 4, 2007 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00323999 | Hysteroscopic Monopolar and Bipolar Resection | unknown | N/A | — | Ullevaal University HospitalOTHER | 1 | May 10, 2006 | clinicaltrials |
| NCT00131417 | Ready to Use Therapeutic Food in the Rehabilitation of Severely Malnourished Children | unknown | Phase 3 | 128 | Makerere UniversityOTHER | 2 | Oct 5, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials